Clinical trial
Lung Cancer Early Molecular Assessment Trial
NCT02894853 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lung Cancer Early Molecular Assessment Trial
- Lead sponsor
- The Netherlands Cancer Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2016
- Completion date
- December 31, 2019
- Enrollment
- 1,297 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.